Inotiv, Inc. (NOTV) Tops Q4 EPS by 8c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update
December 3, 2025 4:05 PM ESTÂ Fourth quarter fiscal 2025 revenue up 5.9% to $138.1 million
 Fiscal 2025 revenue increased 4.5% to $513.0 million
 Fourth quarter fiscal 2025 operating loss decreased 48.5% to $6.8 million
 Fiscal 2025 operating loss decreased 64.2% to $30.9 million
 Conference call scheduled for today at 4:30 pm ET
WEST LAFAYETTE, Ind., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the Company), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results for the three months (Q4 FY 2025) ended September 30, 2025, and twelve months ("FY 2025") ended September 30, 2025.
... More